Your account is not claimed yet. You can sign up with ORCID to claim your account.

Giovanni Bottegoni

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 9

Top Venues

Journal of medicinal chemistry

Journal of chemical information and modeling

ChemMedChem

Science advances

University of Birmingham

University of Bologna (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Birmingham Dec 3o 2018

United Kingdom

Senior Lecturer :: School of Pharmacy

Education History

University of Bologna Sep 1o 1995 - Mar 25o 2002

Italy

MSC :: FaBit

Publications

Pedro J Buigues, Sascha Gehrke, Magd Badaoui, Balint Dudas, Gaurav Mandana, Tianyun Qi, Giovanni Bottegoni, Edina Rosta
Investigating the Unbinding of Muscarinic Antagonists from the Muscarinic 3 Receptor. Journal of chemical theory and computation (2023)
Rita Maria Concetta Di Martino, Andrea Cavalli, Giovanni Bottegoni
Dopamine D3 receptor ligands: a patent review (2014-2020). Expert opinion on therapeutic patents 32 (6) (2022)
Sally A Clayton, Kalbinder K Daley, Lucy MacDonald, Erika Fernández-Vizarra, Giovanni Bottegoni, John D O'Neil, Triin Major, Daniel Griffin, Qinqin Zhuang, Adeolu Badi Adewoye, Kieran Woolcock, Simon W Jones, Carl S Goodyear, Aziza Elmesmari, Andrew Filer, Daniel A Tennant, Stefano Alivernini, Christopher Dominic Buckley, Robert D S Pitceathly, Mariola Kurowska-Stolarska, Andrew R Clark
Inflammation causes remodeling of mitochondrial cytochrome c oxidase mediated by the bifunctional gene C15orf48. Science advances 7 (50) (2021)
Paolo Di Fruscia, Anna Carbone, Giovanni Bottegoni, Francesco Berti, Francesca Giacomina, Stefano Ponzano, Chiara Pagliuca, Annalisa Fiasella, Daniela Pizzirani, Jose Antonio Ortega, Andrea Nuzzi, Glauco Tarozzo, Luisa Mengatto, Roberta Giampà, Ilaria Penna, Debora Russo, Elisa Romeo, Maria Summa, Rosalia Bertorelli, Andrea Armirotti, Sine Mandrup Bertozzi, Angelo Reggiani, Tiziano Bandiera, Fabio Bertozzi
Discovery and SAR Evolution of Pyrazole Azabicyclo[3.2.1]octane Sulfonamides as a Novel Class of Non-Covalent N-Acylethanolamine-Hydrolyzing Acid Amidase (NAAA) Inhibitors for Oral Administration. Journal of medicinal chemistry 64 (18) (2021)
Rita Maria Concetta Di Martino, Giovanni Bottegoni, Francesca Seghetti, Debora Russo, Ilaria Penna, Alessio De Simone, Giuliana Ottonello, Sine Mandrup Bertozzi, Andrea Armirotti, Tiziano Bandiera, Federica Belluti, Andrea Cavalli
Multitarget Compounds for Bipolar Disorder: From Rational Design to Preliminary Pharmacokinetic Evaluation. ChemMedChem 15 (11) (2020)
Sergio Decherchi, Giovanni Bottegoni, Andrea Spitaleri, Walter Rocchia, Andrea Cavalli
BiKi Life Sciences: A New Suite for Molecular Dynamics and Related Methods in Drug Discovery. Journal of chemical information and modeling 58 (2) (2018)
Sergio Decherchi, Giovanni Bottegoni, Andrea Spitaleri, Walter Rocchia, Andrea Cavalli
Addendum to BiKi Life Sciences: A New Suite for Molecular Dynamics and Related Methods in Drug Discovery. Journal of chemical information and modeling 58 (8) (2018)
Alessio De Simone, Debora Russo, Gian Filippo Ruda, Alessandra Micoli, Mariarosaria Ferraro, Rita Maria Concetta Di Martino, Giuliana Ottonello, Maria Summa, Andrea Armirotti, Tiziano Bandiera, Andrea Cavalli, Giovanni Bottegoni
Design, Synthesis, Structure-Activity Relationship Studies, and Three-Dimensional Quantitative Structure-Activity Relationship (3D-QSAR) Modeling of a Series of O-Biphenyl Carbamates as Dual Modulators of Dopamine D3 Receptor and Fatty Acid Amide Hydrolase. Journal of medicinal chemistry 60 (6) (2017)
Federica Prati, Giovanni Bottegoni, Maria Laura Bolognesi, Andrea Cavalli
BACE-1 Inhibitors: From Recent Single-Target Molecules to Multitarget Compounds for Alzheimer's Disease. Journal of medicinal chemistry 61 (3) (2017)

Giovanni Bottegoni.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Giovanni Bottegoni